News Detail
Solan, 29 March 2023: In a bid to ensure quality drug production, seven pharmaceutical firms were told to stop manufacturing in various pharmaceutical clusters after they were found not complying with the laid norms as enshrined in the Good Manufacturing Practices (GMP).
Source : The Tribune
quality drug production
pharmaceutical firms
stop manufacturing
Good Manufacturing Practices
GMP
spurious drugs
Baddi-Barotiwala-Nalagarh industrial belt
State Drugs Controller Navneet Marwaha
stop manufacturing
Related News
- Gujarat FDCA attributes 45% of drug samples failing quality tests due to dissolution testing (25-09-2023)
- CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)
- Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)
- Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)
- 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)
- Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)
- Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)
- One Arrested by Cachar Police with 18,000 Yaba Tablets (24-09-2023)
- Indian-origin girl receives first rejection-free kidney from mother in UK (24-09-2023)
- 3D-printed medical devices gain ground (24-09-2023)